Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Claire Ernst, director of government affairs, Medical Group Management Association (MGMA), explains the list of priorities for the association. These include staving off the large, planned 2023 Medicare reimbursement cuts, fighting for continuation of reimbursements for telehealth, and revamping prior authorizations.

VIDEO: Top priorities for the Medical Group Management Association in 2022

Claire Ernst, director of government affairs, Medical Group Management Association (MGMA), explains the list of priorities for the association, include staving off the large Medicare reimbursement cuts, continuation of telehealth reimbursements, and revamping prior authorizations. 

FDA adds diabetes medicine to drug shortage list

A diabetes treatment drug, Mounjaro, has been added to the Food and Drug Administration’s (FDA) list of drug shortages.

Thumbnail

Chicago physician indicted in $9.5M healthcare fraud conspiracy

Benjamin T. Toh, of Chicago faces up to 10 years in prison and a $250,000 fine.

coronavirus COVID-19 vaccine vaccination

Biden’s winter preparedness plan includes more free COVID-19 tests

The Biden administration plans to make more free, at-home COVID-19 tests available to Americans as part of its newly announced winter preparedness plan.

Congress dome capitol Washington

AMA, state associations urge Congress to avoid Medicare payment cuts

The American Medical Association is asking Congress to step in before new Medicare payment cuts go into effect in 2023.

insurance payer payment insurer

CMS proposes ACA expansion on behavioral health, special enrollment

 The revisions impact insurers operating on the Affordable Care Act marketplace.

Thumbnail

Millions will lose Medicaid coverage when COVID-19 PHE ends

The PHE has been in effect since the early days of the pandemic, and it has been reaffirmed every 90 days since. CMS has indicated it will give healthcare stakeholders at least 60 days’ notice before winding down the PHE.

Congress focused on mental health, Medicare price negotiations as 2023 approaches

With the midterms in the rearview, the lameduck Congress is focused on a handful of healthcare priorities heading into 2023, including mental health and implementing recent Medicare price negotiations afforded in the Inflation Reduction Act.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.